BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto Y, Sugiura T, Todaka A, Okamura Y, Ito T, Ashida R, Kakuda Y, Nakanuma Y, Uesaka K. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value. World J Surg 2018;42:3331-40. [DOI: 10.1007/s00268-018-4605-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xing H, Zhang WG, Cescon M, Liang L, Li C, Wang MD, Wu H, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Schwartz M, Pawlik TM, Serenari M, Shen F, Wu MC, Yang T. Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB (Oxford) 2020;22:677-89. [PMID: 31607637 DOI: 10.1016/j.hpb.2019.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
2 Binicier OB, Pakoz ZB. CA 19-9 levels in patients with acute pancreatitis due to gallstone and metabolic/toxic reasons. Rev Assoc Med Bras (1992). 2019;65:965-970. [PMID: 31389506 DOI: 10.1590/1806-9282.65.7.965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Nakanuma Y, Uesaka K. The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System. J Gastrointest Surg 2020;24:786-95. [PMID: 31012045 DOI: 10.1007/s11605-019-04185-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Jaklitsch M, Petrowsky H. The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma. Transl Gastroenterol Hepatol 2019;4:23. [PMID: 31143844 DOI: 10.21037/tgh.2019.03.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
5 Qiang Z, Zhang H, Jin S, Yan C, Li Z, Tao L, Yu H. The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection. World J Surg Oncol 2021;19:316. [PMID: 34715880 DOI: 10.1186/s12957-021-02426-9] [Reference Citation Analysis]
6 Cheng Z, Lei Z, Jin X, Zhang Q, Si A, Yang P, Zhou J, Hartmann D, Hüser N, Shen F. Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis. J Gastrointest Oncol 2021;12:819-30. [PMID: 34012669 DOI: 10.21037/jgo-20-443] [Reference Citation Analysis]
7 Ma X, Liu L, Fang J, Rao S, Lv L, Zeng M, Shi Y, Yang C. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma. Cancer Imaging 2020;20:40. [PMID: 32576283 DOI: 10.1186/s40644-020-00318-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chen Q, Li F, Gao Y, Xue H, Li Z, Zou Q, Xia Y, Wang K, Shen F. Developing a Selection-aided Model to Screen Cirrhotic Intrahepatic Cholangiocarcinoma for Hepatectomy. J Cancer 2020;11:5623-34. [PMID: 32913457 DOI: 10.7150/jca.46587] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Palen A, Garnier J, Hobeika C, Ewald J, Gregoire E, Delpero JR, Le Treut YP, Turrini O, Hardwigsen J. Oncological relevance of major hepatectomy with inferior vena cava resection for intrahepatic cholangiocarcinoma. HPB (Oxford) 2021:S1365-182X(21)00044-7. [PMID: 33731313 DOI: 10.1016/j.hpb.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Moro A, Mehta R, Sahara K, Tsilimigras DI, Paredes AZ, Farooq A, Hyer JM, Endo I, Shen F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Soubrane O, Koerkamp BG, Sasaki K, Pawlik TM. The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2020;27:2888-901. [DOI: 10.1245/s10434-020-08350-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]